Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation
Meiting Gong1,2, Xiaoqing Fan3,4, Huihan Yu1
1Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, No. 81, Meishan Road, Hefei, 230032, Anhui, China.
Abstract:
There is an ongoing debate regarding whether gliomas originate due to functional or genetic changes in neural stem cells (NSCs). Genetic engineering has made it possible to use NSCs to establish glioma models with the pathological features of human tumors. Here, we found that RAS, TERT, and p53 mutations or abnormal expression were associated with the occurrence of glioma in the mouse tumor transplantation model. Moreover, EZH2 palmitoylation mediated by ZDHHC5 played a significant role in this malignant transformation. EZH2 palmitoylation activates H3K27me3, which in turn decreases miR-1275, increases glial fibrillary acidic protein (GFAP) expression, and weakens the binding of DNA methyltransferase 3A (DNMT3A) to the OCT4 promoter region. Thus, these findings are significant because RAS, TERT, and p53 oncogenes in human neural stem cells are conducive to a fully malignant and rapid transformation, suggesting that gene changes and specific combinations of susceptible cell types are important factors in determining the occurrence of gliomas.
Insights
Glioma development involves genetic changes in neural stem cells (NSCs). Specific mutations (RAS, TERT, p53) and EZH2 palmitoylation drive malignant transformation, impacting key molecular pathways.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- The origin of gliomas, a type of brain tumor, is debated, with theories focusing on functional or genetic alterations in neural stem cells (NSCs).
- Advances in genetic engineering allow for the creation of NSC-based glioma models that mimic human tumor pathology.
Purpose of the Study:
- To investigate the genetic and molecular mechanisms underlying glioma development in neural stem cells.
- To identify key oncogenes and molecular pathways involved in the malignant transformation of NSCs.
Main Methods:
- Utilized a mouse tumor transplantation model with genetically engineered neural stem cells.
- Analyzed the roles of RAS, TERT, and p53 mutations/expression in glioma occurrence.
- Investigated the mechanism of EZH2 palmitoylation mediated by ZDHHC5.
Main Results:
- RAS, TERT, and p53 mutations/abnormal expression were linked to glioma formation.
- EZH2 palmitoylation, facilitated by ZDHHC5, was crucial for malignant transformation.
- EZH2 palmitoylation led to increased H3K27me3, decreased miR-1275, elevated GFAP, and reduced DNMT3A binding to the OCT4 promoter.
Conclusions:
- Specific oncogenes (RAS, TERT, p53) in human NSCs promote rapid malignant transformation.
- Gene alterations combined with susceptible cell types are critical determinants for glioma occurrence.
- The EZH2 palmitoylation pathway represents a significant mechanism in glioma pathogenesis.
More Related Videos
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
